Air Products & Chemicals, Inc.: Form 10-Q for the period ended Dec 31, 2013
Filed with the SEC on Jan 29, 2014 and accepted by EDGAR at Jan 29, 2014, 15:17 ET.
Management's discussion and analysis
As filed, 26,135 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
(Millions of dollars, except for share data)
The disclosures in this quarterly report are complementary to those made in our 2013 Form 10-K. An analysis of results for the first quarter of 2014 is provided in the Management’s Discussion and Analysis to follow.
All comparisons in the discussion are to the corresponding prior year unless otherwise stated. All amounts presented are in accordance with U.S. generally accepted accounting principles (GAAP), except as noted.
Captions such as income from continuing operations attributable to Air Products, net income attributable to Air Products from continuing operations and diluted earnings per share attributable to Air Products from continuing operations are simply referred to as “income from continuing operations,” “net income,” and “diluted earnings per share” throughout this Management’s Discussion and Analysis, unless otherwise stated.
FIRST QUARTER 2014 VS. FIRST QUARTER 2013
FIRST QUARTER 2014 IN SUMMARY
- Sales of $2,545.5 decreased 1%, or $16.9. Underlying sales decreased 2%, primarily due to lower volumes in Tonnage Gases, including the exit from the Polyurethane Intermediates business. Higher energy and raw material contractual cost pass-through to customers increased sales 1%.
- Operating income of $385.6 increased 4%, or $13.2, and operating margin of 15.1% increased 60 basis points (bp) primarily from strong results in our Electronics and Performance Materials and Equipment businesses.
- Net income of $287.1 increased 4%, or $10.2, and diluted earnings per share of $1.34 increased 3%, or $.04. A summary table of changes in diluted earnings per share is presented below.
Changes in Diluted Earnings per Share Attributable to Air Products
| Diluted Earnings per Share | Three Months Ended 31 December 2013 | 2012 | Increase (Decrease) |
|---|---|---|---|
| Net Income | $1.35 | $1.31 | $.04 |
| Income from Discontinued Operations | .01 | .01 | — |
| Income from Continuing Operations | $1.34 | $1.30 | $.04 |
| Operating Income (after-tax) | |||
| Underlying business | |||
| Volume | $.12 | ||
| Price/raw materials | (.05) | ||
| Costs | (.01) | ||
| Currency | (.01) | ||
| Operating Income | .05 | ||
| Other (after-tax) | |||
| Equity affiliates’ income | (.01) | ||
| Interest expense | .01 | ||
| Weighted average diluted shares | (.01) | ||
| Other | (.01) | ||
| Total Change in Diluted Earnings per Share from Continuing Operations | $.04 |
RESULTS OF OPERATIONS
Discussion of Consolidated Results
| Three Months Ended 31 December 2013 | 2012 | $ Change | Change | |
|---|---|---|---|---|
| Sales | $2,545.5 | $2,562.4 | $(16.9) | (1)% |
| Operating income | 385.6 | 372.4 | 13.2 | 4% |
| Operating margin | 15.1% | 14.5% | 60bp | |
| Equity affiliates’ income | 38.2 | 41.4 | (3.2) | (8)% |
Sales
| Underlying business | % Change from Prior Year |
|---|---|
| Volume | (2)% |
| Price | —% |
| Currency | —% |
| Energy and raw material cost pass-through | 1% |
| Total Consolidated Change | (1)% |
Underlying sales decreased 2% with volumes down 2% and stable pricing. Sales decreased as lower Tonnage Gases volumes were partially offset by higher volumes in the rest of our business segments. Higher energy and raw material contractual cost pass-through to customers increased sales by 1%.
Operating Income
Operating income of $385.6 increased 4%, or $13.2, primarily due to higher volumes of $31 across most businesses except Tonnage Gases, partially offset by lower recovery of raw material costs in pricing of $13 and higher costs including maintenance in our Tonnage Gases segment.
Equity Affiliates’ Income
Income from equity affiliates of $38.2 decreased $3.2 primarily due to lower results in a Tonnage Gases affiliate and unfavorable currency impacts in South Africa and India.
Selling and Administrative Expense
Selling and administrative expense of $280.9 increased $12.7, including the impacts of inflation. Selling and administrative expense, as a percent of sales, increased from 10.5% to 11.0%.
Research and Development
Research and development expense of $33.5 increased $.2. Research and development expense, as a percent of sales, was 1.3% in 2014 and 2013.
Other Income (Expense), Net
Other income (expense), net of $20.4 increased $8.8. The current year included a gain from the sale of emission credits. Otherwise, no individual items were significant in comparison to the prior year.
Interest Expense
| Three Months Ended 31 December 2013 | 2012 | |
|---|---|---|
| Interest incurred | $40.8 | $42.7 |
| Less: capitalized interest | 7.5 | 6.9 |
| Interest expense | $33.3 | $35.8 |
Interest incurred decreased $1.9. The decrease was driven primarily by a lower average interest rate on the debt portfolio, partially offset by a higher average debt balance.
Effective Tax Rate
The effective tax rate equals the income tax provision divided by income from continuing operations before taxes. The effective tax rate was 24.2% and 24.4% in the first quarter of 2014 and 2013, respectively.
Discontinued Operations
In the third quarter of 2012, we sold the majority of our Homecare business to The Linde Group for total sale proceeds of €590 million ($777) and recognized a gain of $207.4 ($150.3 after-tax, or $.70 per share). In the third quarter of 2012, an impairment charge of $33.5 ($29.5 after-tax, or $.14 per share) was recorded to write down the remaining business, which was primarily in the United Kingdom and Ireland, to its estimated net realizable value. In the fourth quarter of 2013, we recorded an additional charge of $18.7 ($13.6 after-tax, or $.06 per share) to update our estimate of net realizable value. In the first quarter of 2014, we sold the remaining portion of the Homecare business for £6.1 million ($9.8) and recorded a gain on the sale of $2.4.
The Homecare business, which had been previously reported as part of the Merchant Gases business segment, has been accounted for as a discontinued operation. The results of operations and cash flows of this business have been reclassified from the results of continuing operations for all periods presented.
Refer to Note 3, Discontinued Operations, to the consolidated financial statements for additional details on this business.
Segment Analysis
Merchant Gases
| Three Months Ended 31 December 2013 | 2012 | $ Change | Change | |
|---|---|---|---|---|
| Sales | $1,047.7 | $1,009.1 | $38.6 | 4% |
| Operating income | 169.2 | 171.0 | (1.8) | (1)% |
| Operating margin | 16.1% | 16.9% | (80bp) | |
| Equity affiliates’ income | 34.7 | 35.7 | (1.0) | (3)% |
Merchant Gases Sales
| Underlying business | % Change from Prior Year |
|---|---|
| Volume | 4% |
| Price | —% |
| Currency | —% |
| Total Merchant Gases Sales Change | 4% |
Underlying sales increased 4% from the impact of higher volumes of 4% as continued strength in liquid oxygen, nitrogen, and argon was partially offset by packaged gases demand weakness in Europe and supply limitations for helium globally.
In the U.S./Canada, sales increased 4%, with increased volumes of 2% and pricing up 2%. Higher liquid oxygen and nitrogen volumes to oilfield services, chemicals, food, and metals were partially offset by lower helium volumes due to supply limitations. Volumes also increased as a result of our EPCO Carbondioxide Products, Inc. acquisition. Pricing was higher primarily due to higher pricing in liquid oxygen, liquid nitrogen, and helium.
In Europe, sales increased 3%, due to a favorable currency impact of 3%. Volumes were flat as higher liquid oxygen, nitrogen, and argon volumes were offset by lower helium volumes due to supply limitations and lower cylinder volumes as construction and fabrication markets remain weak. Pricing was flat as higher helium pricing was offset by lower pricing in liquid oxygen, nitrogen, and argon.
In Asia, sales increased 6%, with higher volumes of 8% and reduced pricing of 2%. Volumes were higher as higher liquid oxygen, nitrogen, and argon volumes and improved micro-bulk volumes were partially offset by lower helium volumes due to supply limitations. Pricing decreased in liquid oxygen, nitrogen and argon, particularly in China, driven in part by a higher mix of wholesale customers.
In South America, sales decreased 5%, with higher volumes of 1% and higher pricing of 1% more than offset by unfavorable currency impacts of 7%. Volumes were higher due to volumes from a new plant in Brazil, partially offset by lower cylinder volumes and delays in mining and power projects in Indura. Higher pricing in helium was partially offset by lower liquid oxygen and nitrogen pricing.
Merchant Gases Operating Income and Margin
Operating income was lower by $1.8 as higher volumes of $14 were more than offset by higher operating costs of $9 and lower price recovery of costs of $6 as higher liquid oxygen and nitrogen pricing did not fully recover higher power and fuel costs. Operating margin decreased 80 bp from prior year, primarily due to the impact of higher costs.
Merchant Gases Equity Affiliates’ Income
Merchant Gases equity affiliates’ income of $34.7 decreased $1.0 as stronger underlying results were more than offset by unfavorable currency impacts in South Africa and India.
Tonnage Gases
| Three Months Ended 31 December 2013 | 2012 | $ Change | Change | |
|---|---|---|---|---|
| Sales | $808.1 | $898.4 | $(90.3) | (10)% |
| Operating income | 117.6 | 138.1 | (20.5) | (15)% |
| Operating margin | 14.6% | 15.4% | (80bp) |
Tonnage Gases Sales
| Underlying business | % Change from Prior Year |
|---|---|
| Volume | (13)% |
| Energy and raw material cost pass-through | 2% |
| Currency | 1% |
| Total Tonnage Gases Sales Change | (10)% |
Sales decreased 10%, or $90.3. Volumes decreased 13% as strong demand in the U.S. Gulf Coast hydrogen system was more than offset by reduced volumes due to plant outages and lower volumes in Latin America and our polyeurethane intermediates (PUI) business. The lower PUI volumes decreased sales by 3%. As of the end of the first quarter of 2014, our exit from the PUI business is complete. Higher energy contractual cost pass-through to customers increased sales by 2% and favorable currency impacts increased sales by 1%.
Tonnage Gases Operating Income and Margin
Operating income was lower by 15% primarily from lower volumes of $13 and higher operating costs, including maintenance costs, of $8. Operating margin decreased 80 bp from the prior year, primarily due to the lower volumes and higher maintenance costs.
Electronics and Performance Materials
| Three Months Ended 31 December 2013 | 2012 | $ Change | Change | |
|---|---|---|---|---|
| Sales | $579.1 | $549.0 | $30.1 | 5% |
| Operating income | 83.5 | 61.3 | 22.2 | 36% |
| Operating margin | 14.4% | 11.2% | 320bp |
Electronics and Performance Materials Sales
| Underlying business | % Change from Prior Year |
|---|---|
| Volume | 6% |
| Price | (1)% |
| Currency | —% |
| Total Electronics and Performance Materials Sales Change | 5% |
Sales increased 5% from higher volumes of 6% partially offset by lower pricing of 1%. Electronics sales were up 4% due to higher equipment and onsite sales and higher materials volumes partially offset by the impact of product exits. Performance Materials sales increased 8% from higher volumes across all product lines and all major regions. The volume growth was driven by strength in the automobile, coatings, and North America housing markets while we continued to see weakness in non-residential construction.
Electronics and Performance Materials Operating Income and Margin
Operating income increased 36%, or $22.2, primarily due to higher volumes of $19 and lower costs of $12, partially offset by lower recovery of raw material costs in pricing of $8. The lower costs included the benefits of our recent business restructuring and cost reduction actions. Operating margin of 14.4% increased 320 bp primarily due to the higher volumes and lower costs.
Equipment and Energy
| Three Months Ended 31 December 2013 | 2012 | $ Change | Change | |
|---|---|---|---|---|
| Sales | $110.6 | $105.9 | $4.7 | 4% |
| Operating income | 20.5 | 8.4 | 12.1 | 144% |
Equipment and Energy Sales and Operating Income
Sales of $110.6 and operating income of $20.5 increased primarily from higher LNG activity.
The sales backlog for the Equipment business at 31 December 2013 was $343 compared to $402 at 30 September 2013.
Other
Other operating income (loss) primarily includes other expense and income that cannot be directly associated with the business segments, including foreign exchange gains and losses. Also included are LIFO inventory adjustments, as the business segments use FIFO, and the LIFO pool adjustments are not allocated to the business segments.
Other operating loss was $(5.2) versus $(6.4) in the prior year. The decrease in loss was primarily due to the year on year impact of the LIFO pool inventory adjustment. No other individual items were significant in comparison to the prior year.
PENSION BENEFITS
Pension funding includes both contributions to funded plans and benefit payments for unfunded plans, which are primarily non-qualified plans. With respect to funded plans, our funding policy is that contributions, combined with appreciation and earnings, will be sufficient to pay benefits without creating unnecessary surpluses. In addition, we make contributions to satisfy all legal funding requirements while managing our capacity to benefit from tax deductions attributable to plan contributions. For the three months ended 31 December 2013, required contributions to funded pension plans and benefit payments under unfunded pension plans were $31. For the three months ended 31 December 2012, cash contributions were $230, which included voluntary contributions of $220.
Refer to Note 9, Retirement Benefits, to the consolidated financial statements for details on pension cost and cash contributions.
LIQUIDITY AND CAPITAL RESOURCES
We have maintained a strong financial position through the first three months of 2014. We continue to have consistent access to commercial paper markets and cash flows from operations and financing activities are expected to meet liquidity needs for the foreseeable future.
As of 31 December 2013, we had $375.9 of foreign cash and cash items compared to total cash and cash items of $387.6. If the foreign cash and cash items are needed for operations in the U.S. or we otherwise elect to repatriate the funds, we may be required to accrue and pay U.S. taxes on a significant portion of these amounts. However, since we have significant current investment plans outside the U.S., it is our intent to permanently reinvest the majority of our foreign cash and cash items outside the U.S. Current financing alternatives do not require the repatriation of foreign funds.
The narrative below refers to the consolidated statements of cash flows included on page 6.
Operating Activities
For the first three months of 2014, cash provided by operating activities was $546.2, including income from continuing operations of $287.1. Income from continuing operations is adjusted for non-cash items that include depreciation and amortization, undistributed earnings of equity affiliates, share-based compensation expense, and noncurrent capital lease receivables. The working capital accounts were a use of cash of $24.1, including an increase in trade receivables of $17.7 and a decrease in accounts payable and accrued liabilities of $65.2 which included payments related to the 2013 business restructuring and cost reduction plan of $4.9.
We contributed $31.4 to our pension plans, primarily for plans in the U.K. Management considers various factors when making pension funding decisions, including tax, cash flow, and regulatory implications.
For the first three months of 2013, cash provided by operating activities was $278.4, primarily driven by income from continuing operations of $276.9. We contributed $230.0 to our pension plans, primarily for plans in the U.S.
Investing Activities
For the first three months of 2014, cash used for investing activities was $385.6, primarily driven by capital expenditures for plant and equipment of $391.1.
For the first three months of 2013, cash used for investing activities was $355.8, primarily driven by capital expenditures for plant and equipment of $357.0.
Capital expenditures are detailed in the table below:
| Three Months Ended 31 December 2013 | 2012 | |
|---|---|---|
| Additions to plant and equipment | $391.1 | $357.0 |
| Capital expenditures on a GAAP basis | $391.1 | $357.0 |
| Capital lease expenditures (A) | 48.1 | 71.4 |
| Capital expenditures on a Non-GAAP basis | $439.2 | $428.4 |
(A) We utilize a non-GAAP measure in the computation of capital expenditures and include spending associated with facilities accounted for as capital leases. Certain contracts associated with facilities that are built to provide product to a specific customer are required to be accounted for as leases, and such spending is reflected as a use of cash within cash provided by operating activities, if the arrangements qualifies as a capital lease. The presentation of this non-GAAP measure is intended to enhance the usefulness of information by providing a measure that our management uses internally to evaluate and manage our expenditures.
Financing Activities
For the first three months of 2014, cash used by financing activities was $238.2. Our borrowings (short- and long-term proceeds, net of repayments) were a net use of cash of $93.5, driven primarily by the repayment of a 3.75% Eurobond of €300 million ($401.0) in November 2013, partially offset by an increase in commercial paper and short-term borrowings of $339.1. The primary additional use of cash was to pay dividends of $149.9.
For the first three months of 2013, cash provided by financing activities was $157.1. Our borrowings (short- and long-term proceeds, net of repayments) were a net source of cash of $721.4, driven primarily by an increase in commercial paper and short-term borrowings of $709.1. Primary uses of cash were to purchase 5.7 million shares of treasury stock for $461.6 and to pay dividends of $136.0.
Discontinued Operations
For the first three months of 2014, cash provided by discontinued operations was $10.5. The sale of the remaining Homecare business, which was primarily in the United Kingdom and Ireland, generated proceeds of £6.1 million ($9.8) and a $2.4 gain which are included in discontinued operations in the consolidated statements of cash flows. Refer to Note 3, Discontinued Operations, to the consolidated financial statements for additional information.
Financing and Capital Structure
Total debt at 31 December 2013 and 30 September 2013, expressed as a percentage of the sum of total debt and total capitalization (total debt plus total equity plus redeemable noncontrolling interest), was 44.2% and 45.3%, respectively. Total debt decreased from $6,273.6 at 30 September 2013 to $6,168.3 at 31 December 2013.
During fiscal 2013, we entered into a five-year $2,500.0 revolving credit agreement with a syndicate of banks maturing 30 April 2018 (the “2013 Credit Agreement”), under which senior unsecured debt is available to both the Company and certain of its subsidiaries. The 2013 Credit Agreement provides a source of liquidity for the Company and supports its commercial paper program. The Company’s only financial covenant is a maximum ratio of total debt to total capitalization of 70%. No borrowings were outstanding under the 2013 Credit Agreement as of 31 December 2013.
Effective 11 June 2012, we entered into an offshore Chinese Renminbi (RMB) syndicated credit facility of RMB1,000.0 million ($165.1), maturing in June 2015. There are RMB250.0 million ($41.3) in outstanding borrowings under this commitment at 31 December 2013. Additional commitments totaling $318.8 are maintained by our foreign subsidiaries, of which $270.9 was borrowed and outstanding at 31 December 2013.
As of 31 December 2013, we are in compliance with all of the financial and other covenants under our debt agreements.
As of 31 December 2013, we classified $400.0 of commercial paper as long-term debt because we have the ability to refinance the debt under the 2013 Credit Agreement. Our current intent is to refinance this debt via the U.S. or European public or private placement markets.
On 15 September 2011, the Board of Directors authorized the repurchase of up to $1,000 of our outstanding common stock. During the first three months of fiscal year 2014, no shares were purchased. At 31 December 2013, $485.3 in share repurchase authorization remains.
CONTRACTUAL OBLIGATIONS
We are obligated to make future payments under various contracts such as debt agreements, lease agreements, unconditional purchase obligations, and other long-term obligations. Other than the repayment of a maturing 3.75% Eurobond of €300 million ($401.0) in November 2013, there have been no material changes to contractual obligations since 30 September 2013.
COMMITMENTS AND CONTINGENCIES
Other than the operations guarantee associated with the sale of the remaining portion of the Homecare business as discussed in Note 3, Discontinued Operations, to the consolidated financial statements, there have been no material changes to commitments and contingencies since 30 September 2013. For current updates on Litigation and Environmental matters, refer to Note 10, Commitments and Contingencies, in this quarterly filing.
OFF-BALANCE SHEET ARRANGEMENTS
There have been no material changes to off-balance sheet arrangements since 30 September 2013. We are not a primary beneficiary in any material variable interest entity. Our off-balance sheet arrangements are not reasonably likely to have a material impact on financial condition, changes in financial condition, and results of operations or liquidity.
RELATED PARTY TRANSACTIONS
Our principal related parties are equity affiliates operating in the industrial gas business. We did not engage in any material transactions involving related parties that included terms or other aspects that differ from those which would be negotiated at arm’s length with clearly independent parties.
CRITICAL ACCOUNTING POLICIES AND ESTIMATES
Management’s Discussion and Analysis of our financial condition and results of operations is based on the consolidated financial statements and accompanying notes that have been prepared in accordance with U.S. generally accepted accounting principles. The preparation of these financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Information concerning our implementation and impact of new accounting standards issued by the FASB is included in Note 2, New Accounting Guidance, to the consolidated financial statements. There have been no changes in accounting policy in the current period that had a material impact on our financial condition, change in financial condition, liquidity, or results of operations.
NEW ACCOUNTING GUIDANCE
See Note 2, New Accounting Guidance, to the consolidated financial statements for information concerning our implementation and impact of new accounting guidance.
FORWARD-LOOKING STATEMENTS
This report contains “forward-looking statements” within the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, including statements about management’s expectations. These forward-looking statements are based on management’s reasonable expectations and assumptions as of the date this report is filed. Actual performance and financial results may differ materially from projections and estimates expressed in the forward-looking statements because of many factors not anticipated by management, including, without limitation, weakening or reversal of global or regional economic recovery; future financial and operating performance of major customers; unanticipated contract terminations or customer cancellations or postponement of projects and sales; unanticipated asset impairments or losses; the impact of competitive products and pricing; interruption in ordinary sources of supply of raw materials; the impact of price fluctuations in natural gas; the ability to recover unanticipated increased energy and raw material costs from customers; costs and outcomes of litigation or regulatory investigations; the success of productivity programs; the timing, impact, and other uncertainties of future acquisitions or divestitures; significant fluctuations in interest rates and foreign currencies from that currently anticipated; political risks, including the risks of unanticipated government actions that may result in project delays, cancellations or expropriations; the impact of changes in environmental tax or other legislation and regulations in jurisdictions in which the Company and its affiliates operate; the impact on the effective tax rate of changes in the mix of earnings among our U.S. and international operations; and other risk factors described in the Company’s Form 10-K for its fiscal year ended 30 September 2013. The Company disclaims any obligation or undertaking to disseminate any updates or revisions to any forward-looking statements contained in this document to reflect any change in the Company’s assumptions, beliefs or expectations or any change in events, conditions, or circumstances upon which any such forward-looking statements are based.
Market risk
As filed, 912 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
Information on our utilization of financial instruments and an analysis of the sensitivity of these instruments to selected changes in market rates and prices is included in our 2013 Form 10-K.
There were no material changes to the sensitivity analysis related to interest rate risk on the fixed portion of our debt portfolio since 30 September 2013.
There were no material changes to the sensitivity analysis related to the variable portion of our debt portfolio since 30 September 2013.
There were no material changes to market risk sensitivities for foreign exchange rate risk since 30 September 2013.
The net financial instrument position decreased from a liability of $5,719.5 at 30 September 2013 to a liability of $5,280.4 at 31 December 2013. The decrease is primarily due to the repayment of a 3.75% Eurobond of €300 million ($401.0) in November 2013, which reduced the book value of long-term debt.
Controls and procedures
As filed, 928 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
We maintain a comprehensive set of disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act). As of 31 December 2013 (the Evaluation Date), an evaluation of the effectiveness of our disclosure controls and procedures was carried out under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer. Based upon that evaluation, the Chief Executive Officer and Chief Financial Officer concluded that, as of the end of the period covered by this report these disclosure controls and procedures were effective.
During the quarter ended on the Evaluation Date, there was no change in internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2013-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2013-10-01 to 2013-12-31 | $2.55bn | us-gaap:SalesRevenueNet |
| Cost of revenue | 3 months2013-10-01 to 2013-12-31 | $1.87bn | us-gaap:CostOfGoodsAndServicesSold |
| Research and development | 3 months2013-10-01 to 2013-12-31 | $33.5m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months2013-10-01 to 2013-12-31 | $280.9m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2013-10-01 to 2013-12-31 | $385.6m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2013-10-01 to 2013-12-31 | $33.3m | us-gaap:InterestExpense |
| Income tax | 3 months2013-10-01 to 2013-12-31 | $94.5m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2013-10-01 to 2013-12-31 | $290.2m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2013-10-01 to 2013-12-31 | $1.35 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2013-10-01 to 2013-12-31 | $1.37 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2013-10-01 to 2013-12-31 | 214,300,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months2013-10-01 to 2013-12-31 | $546.2m | us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations |
| Capital expenditure | 3 months2013-10-01 to 2013-12-31 | $391.1m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 3 months2013-10-01 to 2013-12-31 | $149.9m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 3 months2013-10-01 to 2013-12-31 | $0 | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2013-12-31 | $387.6m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2013-12-31 | $3.33bn | us-gaap:AssetsCurrent |
| Total assets | At period end2013-12-31 | $17.92bn | us-gaap:Assets |
| Current liabilities | At period end2013-12-31 | $3.15bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2013-12-31 | $10.13bn | us-gaap:Liabilities |
| Long-term debt | At period end2013-12-31 | $5.02bn | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2013-12-31 | $117.0m | us-gaap:LongTermDebtCurrent |
| Short-term borrowings | At period end2013-12-31 | $1.03bn | us-gaap:ShortTermBorrowings |
| Shareholders' equity | At period end2013-12-31 | $7.26bn | us-gaap:StockholdersEquity |
| Shares outstanding | At period end2013-12-31 | 211,672,884 shares | dei:EntityCommonStockSharesOutstanding |
Source: SEC EDGAR, the filing index for accession 0001193125-14-025630. Last ingested by Listed: Nov 5, 2026, 11:28 ET. Listed shows no prices and gives no investment advice.